ICU MEDICAL INC/DE Quarterly Liabilities and Equity in USD from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Icu Medical Inc/De quarterly Liabilities and Equity history and growth rate from Q1 2010 to Q2 2024.
  • Icu Medical Inc/De Liabilities and Equity for the quarter ending June 30, 2024 was $4.29B, a 3.95% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $4.29B -$176M -3.95% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $4.29B -$182M -4.08% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $4.38B -$137M -3.04% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $4.38B -$73.6M -1.65% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $4.46B -$127M -2.77% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $4.47B -$276M -5.82% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $4.52B +$2.63B +140% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $4.45B +$2.61B +142% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $4.59B +$2.79B +155% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $4.75B +$2.98B +169% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $1.88B +$117M +6.64% Dec 31, 2021 10-K 2023-02-27
Q3 2021 $1.84B +$110M +6.35% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $1.8B -$56.2M -3.02% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $1.77B -$51.7M -2.85% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $1.76B +$71.3M +4.21% Dec 31, 2020 10-K 2022-02-25
Q3 2020 $1.73B +$91.8M +5.6% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $1.86B +$236M +14.6% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $1.82B +$204M +12.6% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $1.69B +$107M +6.75% Dec 31, 2019 10-K 2021-02-26
Q3 2019 $1.64B +$92.6M +5.99% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $1.62B +$96.6M +6.33% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $1.61B +$121M +8.07% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $1.59B +$88.4M +5.91% Dec 31, 2018 10-K 2020-03-02
Q3 2018 $1.55B +$22.2M +1.46% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $1.53B +$39M +2.63% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $1.49B +$19.7M +1.34% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $1.5B +$792M +112% Dec 31, 2017 10-K 2019-03-01
Q3 2017 $1.52B +$834M +121% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $1.49B +$824M +124% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $1.47B +$837M +132% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 $705M +$77.9M +12.4% Dec 31, 2016 10-K 2018-03-16
Q3 2016 $689M +$78.5M +12.9% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $663M +$93.1M +16.3% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $636M +$81.6M +14.7% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $627M +$85.7M +15.8% Dec 31, 2015 10-K 2017-03-01
Q3 2015 $610M +$82.5M +15.6% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 $570M +$50.7M +9.76% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 $554M +$47.9M +9.46% Mar 31, 2015 10-Q 2015-05-06
Q4 2014 $541M +$41.5M +8.3% Dec 31, 2014 10-K 2016-02-26
Q3 2014 $528M +$59M +12.6% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $520M +$68M +15% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 $506M +$68.6M +15.7% Mar 31, 2014 10-Q 2014-05-07
Q4 2013 $500M +$71.1M +16.6% Dec 31, 2013 10-K 2015-02-20
Q3 2013 $469M +$55.8M +13.5% Sep 30, 2013 10-Q 2013-10-22
Q2 2013 $452M +$59M +15% Jun 30, 2013 10-Q 2013-07-25
Q1 2013 $438M +$61.4M +16.3% Mar 31, 2013 10-Q 2013-04-22
Q4 2012 $429M +$67.4M +18.7% Dec 31, 2012 10-K 2014-02-21
Q3 2012 $413M +$69.4M +20.2% Sep 30, 2012 10-Q 2012-10-19
Q2 2012 $393M +$46.3M +13.4% Jun 30, 2012 10-Q 2012-07-20
Q1 2012 $376M +$47.3M +14.4% Mar 31, 2012 10-Q 2012-04-20
Q4 2011 $361M +$51.5M +16.6% Dec 31, 2011 10-K 2013-02-26
Q3 2011 $344M +$43.1M +14.3% Sep 30, 2011 10-Q/A 2011-12-08
Q2 2011 $346M +$59.7M +20.8% Jun 30, 2011 10-Q/A 2011-12-08
Q1 2011 $329M +$42.3M +14.7% Mar 31, 2011 10-Q 2011-04-22
Q4 2010 $310M Dec 31, 2010 10-K 2012-03-23
Q3 2010 $300M Sep 30, 2010 10-Q 2010-10-22
Q2 2010 $287M Jun 30, 2010 10-Q 2010-07-23
Q1 2010 $287M Mar 31, 2010 10-Q 2010-04-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.